Medicine. Stroke--tPA and the clinic.
Where this comes from
- Record sourced from PubMed, PMID 14500967.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical trial results are not always rapidly incorporated into routine medical practice. This Policy Forum describes a variety of barriers that have impeded the more widespread use of thrombolytic therapy (tPA, tissue plasminogen activator) for selected patients with acute ischemic stroke. These barriers are not insurmountable but will require a concerted effort to overcome.
Medical subject headings
- Brain Ischemia
- Delivery of Health Care
- Stroke
- Tissue Plasminogen Activator